Hi rgc,
You probably have no idea who I am but I remember your posts on Oncosil and Biotron amongst others and you seem to have a background in healthcare.
I see you hold Immuron and have your sentiment as a Hold. Are you able to provide your opinion on Immuron's NASH Phase II results?
I asked Southoz who very kindly indicated the presentation of the announcement wasn't the greatest but that the trial seemed to be robust.
.85-95 ASX ($25-$30 USD) by June 2018, page-49
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6300 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 45000 | 1 |
View Market Depth
| Last trade - 16.12pm 13/11/2024 (20 minute delay) ? |
| IMC (ASX) Chart |
Day chart unavailable